9th Annual Association for Bariatric Endoscopy (ABE) Meeting | May 2024 ABEAM2024-State of the Art Lecture: Metabolic Surgery in 2024

Pdf Summary

Metabolic surgery in 2024 is highlighted as a promising intervention, with past contraindications now becoming indications for the future. Dr. Omar Ghanem discusses the potential of metabolic surgery in various medical contexts. The importance of metabolic surgery in addressing diabetes, especially in terms of long-term remission rates, is emphasized in the presentation. Studies demonstrate the benefits of metabolic surgery in high-risk populations such as septuagenarians and patients with high BMI, showcasing low mortality and complication rates. Additionally, the role of metabolic surgery as a bridge for other medical conditions like neoplasms, heart failure, and inflammatory diseases is explored. The presentation underscores the significant impact of metabolic surgery on reducing cancer risk and the potential for non-hormonal cancer risk reduction post-surgery. The use of metabolic surgery as a bridge for neoplastic therapy and its implications for improving patient outcomes are discussed. Overall, the presentation sheds light on the evolving landscape of metabolic surgery, highlighting its potential to improve various health conditions and outcomes.

Asset Subtitle

Omar M. Ghanem, MD, FACS

Keywords

Metabolic surgery

Dr. Omar Ghanem

Diabetes remission

High-risk populations

Septuagenarians

High BMI

Cancer risk reduction

Non-hormonal cancer risk reduction

Neoplastic therapy

Health outcomes